Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
The Journal of Urology|December 18, 2007
The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT studyClaus G Roehrborn, Paul Siami, Jack Barkin, et al.
BJU International|October 17, 2013
Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT studyClaus G Roehrborn, Jack Barkin, Andrea Tubaro, et al.
The Canadian Journal of Urology|March 7, 2017
Improving prostate cancer care collaboratively - a multidisciplinary, formal, consensus-based approachAndrew Loblaw, Jack Barkin, Roger Buckley, et al.
BJU International|February 22, 2011
Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trialClaus G Roehrborn, Jack Barkin, Paul Siami, et al.
Contemporary Clinical Trials|September 1, 2007
Combination therapy with dutasteride and tamsulosin in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement: the CombAT (Combination of Avodart and Tamsulosin) trial rationale and study designPaul Siami, Claus G Roehrborn, Jack Barkin, et al.
Clinical Therapeutics|September 1, 2004
A randomized, double-blind, parallel-group comparison of controlled- and immediate-release oxybutynin chloride in urge urinary incontinenceJack Barkin, Jacques Corcos, Sidney Radomski, et al.
The Canadian Journal of Urology|December 15, 2011
Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single centerDean S Elterman, Jack Barkin, Sidney B Radomski, et al.
European Urology|November 18, 2008
The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT studyClaus G Roehrborn, Paul Siami, Jack Barkin, et al.
European Urology|October 15, 2009
The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT studyClaus G Roehrborn, Paul Siami, Jack Barkin, et al.
BJU International|April 26, 2014
Multicentre prospective crossover study of the 'prostatic urethral lift' for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasiaAnthony L Cantwell, William K Bogache, Steven F Richardson, et al.
Pageof 7